Piao Yang Sun
Net worth: 12 875 M $ as of 30/01/2026
Net worth: 12 875 M $ as of 30/01/2026
Presently, Piao Yang Sun occupies the position of Chairman for Jiangsu Hengrui Pharmaceutical Group Co. Ltd. Dr. Sun is also on the board of Jiangsu Hengrui Medicine Co., Ltd. (former Chairman). In his past career he was Chairman for Shanghai Pharmaceuticals Holding Co., Ltd.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 22/05/2025 | 1,538,184,187 ( 24.16% ) | 12 875 M $ | 30/01/2026 |
| Companies | Position | Start |
|---|---|---|
| JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD | Chairman | 07/07/2021 |
| ABBISKO CAYMAN LIMITED | Director/Board Member | 29/09/2021 |
Jiangsu Hengrui Pharmaceutical Group Co. Ltd.
Jiangsu Hengrui Pharmaceutical Group Co. Ltd. Financial ConglomeratesFinance Engages in investment holding | Director/Board Member | 31/01/2020 |
| Companies | Position | End |
|---|---|---|
| SHANGHAI PHARMACEUTICALS HOLDING CO., LTD | Chairman | 19/07/2007 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Pharmaceuticals Holding Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals products | Health Technology |
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products for treatment of cancer | Health Technology |
Nanjing University
Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jiangsu Hengrui Pharmaceutical Group Co. Ltd.
Jiangsu Hengrui Pharmaceutical Group Co. Ltd. Financial ConglomeratesFinance Engages in investment holding | Finance |
China Pharmaceutical University
China Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abbisko Cayman Ltd.
Abbisko Cayman Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to the discovery and development of small molecule oncology therapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition